Innovation:
From unmet clinical needs to value-driven products...

Innovation is intrinsically rooted in our culture and forged by the combined professional experiences of our team.

We innovate with our expertise and experience in medical technology development, understanding medical device regulations, product design, prototyping, detailed product engineering, regulatory testing, and manufacturing.

Our Innovation Approach

Omya sums up the approach to medical technology innovation in four core principles.

Our innovation is
‘Defined by Clinical Needs’

We are trained to observe, articulate, and validate unmet clinical needs in clinical settings. We objectively determine that our patients are best served by product, process, or business model innovation or a combination of all of these.

Our products are
‘Designed for Performance’

We develop solutions that firmly embody patient safety and clinical performance. We design features that pay minute attention to detail to maximize diagnostic and therapeutic benefit and minimize errors, risk, and pain…

Our products are
‘Driven by Value’

Innovating for Value is our foundational belief and philosophy. Our products present credible evidence of clinical and economic value. The effectiveness of care delivery, being driven by a value provides an additional advantage.

Our solutions are
‘Delivered with Diligence’

We strive to exceed international standards of quality, safety, & performance for regulatory approvals. We refine our design, manufacturing processes concurrently with rigorous validation in the engineering & clinical domains.

BioScoop™: Our flagship soft-tissue core biopsy system

A comprehensive example of our innovative approach, the BioScoop™ Soft-tissue core biopsy system is designed to deliver unmatched performance and value through “first-time-right” biopsies for a range of soft tissues. Concurrent delivery of the hemostatic agent for unprecedented safety during automated, touchless extraction and transfer of full-core samples is designed to improve operator confidence and help deliver a definitive diagnosis in potentially life-threatening conditions. After rigorous in-house testing, BioScoop™ is undergoing pre-clinical evaluation at select reputed medical centers in India and across the globe in near future.

BioScoop™ and BxSeal™ Technologies are developed by our Subsidiary Indio Labs Private Limited, under a collaboration between Stanford-India Biodesign Programme, the All India Institute of Medical Sciences (Delhi) – the Indian Institute of Technology (Delhi), and the Stanford University (USA), with support from the Department of Biotechnology, Government of India, and licensed by the Biotech Consortium India Limited

Unmet Needs

The BioScoop™ platform was invented to satisfy a compelling unmet need for an

“A simple, safer and more effective method of procuring soft-tissue core biopsy for
definitive diagnosis of underlying pathologies with assisted Hemostasis”.

Design Evolution

Key Innovations

Fostering A Collaborative Innovation Ecosystem

We are glad to serve our local innovation community and help build a collaborative innovation ecosystem. We offer our expertise and experience in MedTech design, prototyping, and detailed product engineering, including testing and manufacturing.
We welcome queries from MedTech innovators looking for support in their innovation journeys. Please submit your non-confidential ideas, concepts, or requests for collaboration using the form below*. We shall evaluate these for conflict of interest and if it matches with our domain expertise, and revert.

Submit Your Innovation Idea

     Choose a file…

     Choose a file…

    We request innovators to submit only non-confidential information at this stage. Omya does not assume responsibility for maintaining confidentiality of any ideas submitted to us for evaluation.

    I agree to have read and understood all the Terms and Conditions

    Menu